Aarey Drugs & Pharmaceuticals Limited (BOM:524412)
India flag India · Delayed Price · Currency is INR
110.10
-5.35 (-4.63%)
At close: Nov 16, 2026

BOM:524412 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
4,1914,7234,7393,9564,1904,928
Other Revenue
9.89--69.65-1.73
4,2014,7234,7394,0264,1904,929
Revenue Growth
-1.90%-0.35%17.73%-3.91%-15.01%40.27%
Cost of Revenue
4,0404,5464,6213,8194,0394,721
Gross Profit
161.13176.75118.23206.4150.87208.51
Selling, General & Admin
11.4613.816.7414.2115.5420.46
Other Operating Expenses
62.2376.6130.8877.552.6767.9
Operating Expenses
108.35118.9467.06108.6983.95108.24
Operating Income
52.7857.8151.1797.7166.92100.27
Interest Expense
-48.26-42.93-35.42-41.95-25.4-18.13
Interest & Investment Income
46.346.356.04-26.3320.09
Currency Exchange Gain (Loss)
0.050.050.48-0.52-4.490.39
Other Non Operating Income (Expenses)
-7.08-7.09-11.23-1.8-3.26-2.24
EBT Excluding Unusual Items
43.7954.1461.0553.4360.1100.37
Other Unusual Items
---0.03---
Pretax Income
43.7954.1461.0253.4360.1100.37
Income Tax Expense
4.1314.4720.786.5922.3934.82
Net Income
39.6639.6840.2446.8437.7165.55
Net Income to Common
39.6639.6840.2446.8437.7165.55
Net Income Growth
10.69%-1.40%-14.09%24.20%-42.47%0.62%
Shares Outstanding (Basic)
302828252524
Shares Outstanding (Diluted)
302828252524
Shares Change
6.89%-11.96%-0.26%5.84%2.95%
EPS (Basic)
1.301.391.411.841.482.72
EPS (Diluted)
1.301.391.411.841.482.72
EPS Growth
3.65%-1.42%-23.37%24.32%-45.59%-2.36%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-317.06-22.7250.96-37.16-23.25-17.03
Free Cash Flow Per Share
-10.43-0.801.79-1.46-0.91-0.71
Gross Margin
3.84%3.74%2.50%5.13%3.60%4.23%
Operating Margin
1.26%1.22%1.08%2.43%1.60%2.03%
Profit Margin
0.94%0.84%0.85%1.16%0.90%1.33%
Free Cash Flow Margin
-7.55%-0.48%1.07%-0.92%-0.56%-0.34%
EBITDA
87.4486.3470.62114.6982.66120.15
EBITDA Margin
2.08%1.83%1.49%2.85%1.97%2.44%
D&A For EBITDA
34.6728.5319.4516.9815.7419.88
EBIT
52.7857.8151.1797.7166.92100.27
EBIT Margin
1.26%1.22%1.08%2.43%1.60%2.03%
Effective Tax Rate
9.43%26.72%34.05%12.34%37.25%34.69%
Revenue as Reported
4,2624,7844,8384,0264,2174,954
Advertising Expenses
-0.893.361.712.563.89